Precision Neuroscience releases a detailed map of the human nervous system based on data from **70 patients**, covering the cortex, brainstem, and spinal cord. The dataset supports the company’s **Precision system**, which has now surpassed **100 patient implants**. Researchers aim to improve neural interface accuracy and therapeutic applications through this expanded anatomical reference.
Precision Neuroscience, a New York City-based developer of brain-computer interfaces, raises $250 million in a Series D round at a valuation above $1 billion. The financing brings its total funding to $430 million. Bill Ackman's backing places him alongside Elon Musk and Jeff Bezos as investors entering the emerging brain-computer interface industry.
Sep 2026New York TimesNews article
Precision Neuroscience Closes Oversubscribed $250M Series Dglobenewswire.com/news-release/2026/09/24/3368254/0/en/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund.html
Precision Neuroscience, a brain-computer interface (BCI) company, closes an oversubscribed $250 million Series D financing co-led by Pershing Square, the Ackman Oxman Institute, and a leading life sciences investment fund. The round values the company at just over $1 billion.
Precision Neuroscience and UChicago Medicine launch a clinical partnership to study AI-driven sensorimotor function and neuroprosthetics using Layer 7. The collaboration advances brain-computer interface research.
